search
Back to results

A Prospective Study of Two Daily Disposable Contact Lenses

Primary Purpose

Myopia

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Delefilcon A contact lenses
Etafilcon A contact lenses
Sponsored by
Alcon Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia focused on measuring myopia, contact lenses, dry eyes, comfort, replacement

Eligibility Criteria

18 Years - 43 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Be of legal age of consent and sign written Informed Consent Document and HIPAA form.
  • Currently wearing soft contact lenses and identified as having contact lens-related dryness symptoms based upon responses to the Contact Lens Dry Eye Questionnaire.
  • Wearing either daily disposable contact lenses or bi-weekly/monthly replacement contact lenses, daily wear use only (no extended wear use).
  • Able to achieve distance visual acuity of at least 20/25 in each eye with study lenses in the available parameters, -0.50D to -6.00D.
  • Willing to wear study lenses for at least 8 hours/day and at least 5 days/week.
  • Willing and able to follow instructions and maintain the appointment schedule.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

  • Neophyte or current wearer of DAILIES TOTAL1® or 1-DAY ACUVUE® MOIST™ contact lenses.
  • Requires monovision or presbyopic correction.
  • Any systemic or ocular disease or disorder complicating factors or structural abnormality that would negatively affect the conduct or outcome of the study.
  • Recent (within 7 days of enrollment) or current ocular infection, active ocular inflammation, glaucoma or preauricular lymphadenopathy.
  • Clinically significant lash or lid abnormality.
  • Systemic disease that, in the investigator's best judgment, would prohibit or confound safe contact lens wear.
  • History of ocular surgery/trauma within the last 6 months.
  • Topical or systemic antibiotics use within 7 days of enrollment.
  • Other protocol-defined exclusion criteria may apply.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    DT1

    1DAVM

    Arm Description

    Delefilcon A contact lenses worn bilaterally on a daily wear, daily disposable basis for 4 weeks

    Etafilcon A contact lenses worn bilaterally on a daily wear, daily disposable basis for 4 weeks

    Outcomes

    Primary Outcome Measures

    Mean Change From Baseline in Subjective Contact Lens-related Dryness Symptoms at Week 4 as Assessed by the CLDEQ
    Contact lens symptoms were evaluated using the Contact Lens and Dry Eye Questionnaire (CLDEQ). The participant indicated the frequency with which 9 common contact lens-related ocular surface dryness symptoms were experienced over the previous week. Each symptom was rated on a 5-point scale (1=never, 5=constantly). Both eyes contributed to the mean. A more negative change number indicates a greater perceived improvement, namely, lessening of the symptom.

    Secondary Outcome Measures

    Full Information

    First Posted
    July 6, 2012
    Last Updated
    November 25, 2013
    Sponsor
    Alcon Research
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01636986
    Brief Title
    A Prospective Study of Two Daily Disposable Contact Lenses
    Official Title
    Impact of a Novel Silicone Hydrogel in Reducing Contact Lens-Related Dryness Symptoms in Existing Contact Lens Wearers
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2013
    Overall Recruitment Status
    Completed
    Study Start Date
    July 2012 (undefined)
    Primary Completion Date
    November 2012 (Actual)
    Study Completion Date
    November 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Alcon Research

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study was to evaluate the performance of a novel silicone hydrogel contact lens, DAILIES TOTAL1® (DT1) compared to the standard hydrogel material in 1-DAY ACUVUE® MOIST® (1DAVM) contact lens in contact lens wearers identified as having contact lens-related dryness symptoms.
    Detailed Description
    Three study visits occurred over the course of 28 ± 3 days.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Myopia
    Keywords
    myopia, contact lenses, dry eyes, comfort, replacement

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    62 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    DT1
    Arm Type
    Experimental
    Arm Description
    Delefilcon A contact lenses worn bilaterally on a daily wear, daily disposable basis for 4 weeks
    Arm Title
    1DAVM
    Arm Type
    Active Comparator
    Arm Description
    Etafilcon A contact lenses worn bilaterally on a daily wear, daily disposable basis for 4 weeks
    Intervention Type
    Device
    Intervention Name(s)
    Delefilcon A contact lenses
    Other Intervention Name(s)
    DAILIES TOTAL1®
    Intervention Description
    Silicone hydrogel contact lenses for daily wear, daily disposable use
    Intervention Type
    Device
    Intervention Name(s)
    Etafilcon A contact lenses
    Other Intervention Name(s)
    1-DAY ACUVUE® MOIST™
    Intervention Description
    Hydrogel contact lenses for daily wear, daily disposable use
    Primary Outcome Measure Information:
    Title
    Mean Change From Baseline in Subjective Contact Lens-related Dryness Symptoms at Week 4 as Assessed by the CLDEQ
    Description
    Contact lens symptoms were evaluated using the Contact Lens and Dry Eye Questionnaire (CLDEQ). The participant indicated the frequency with which 9 common contact lens-related ocular surface dryness symptoms were experienced over the previous week. Each symptom was rated on a 5-point scale (1=never, 5=constantly). Both eyes contributed to the mean. A more negative change number indicates a greater perceived improvement, namely, lessening of the symptom.
    Time Frame
    Day 0, Week 4

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    43 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Be of legal age of consent and sign written Informed Consent Document and HIPAA form. Currently wearing soft contact lenses and identified as having contact lens-related dryness symptoms based upon responses to the Contact Lens Dry Eye Questionnaire. Wearing either daily disposable contact lenses or bi-weekly/monthly replacement contact lenses, daily wear use only (no extended wear use). Able to achieve distance visual acuity of at least 20/25 in each eye with study lenses in the available parameters, -0.50D to -6.00D. Willing to wear study lenses for at least 8 hours/day and at least 5 days/week. Willing and able to follow instructions and maintain the appointment schedule. Other protocol-defined inclusion criteria may apply. Exclusion Criteria: Neophyte or current wearer of DAILIES TOTAL1® or 1-DAY ACUVUE® MOIST™ contact lenses. Requires monovision or presbyopic correction. Any systemic or ocular disease or disorder complicating factors or structural abnormality that would negatively affect the conduct or outcome of the study. Recent (within 7 days of enrollment) or current ocular infection, active ocular inflammation, glaucoma or preauricular lymphadenopathy. Clinically significant lash or lid abnormality. Systemic disease that, in the investigator's best judgment, would prohibit or confound safe contact lens wear. History of ocular surgery/trauma within the last 6 months. Topical or systemic antibiotics use within 7 days of enrollment. Other protocol-defined exclusion criteria may apply.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jami Kern, Ph.D.
    Organizational Affiliation
    Alcon Research
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    A Prospective Study of Two Daily Disposable Contact Lenses

    We'll reach out to this number within 24 hrs